Package 0527-2415-32

{"route": ["ORAL"], "spl_id": "5e3c0247-0f79-454e-b14d-1e7dfd1a765e", "openfda": {"upc": ["0305272430419", "0305272415461", "0305272430464", "0305272415416", "0305272430327", "0305272430433", "0305272415324", "0305272415430"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["15c4e95a-d203-4caf-b6c7-44792355cb76"], "manufacturer_name": ["Lannett Company Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-32)", "package_ndc": "0527-2415-32", "marketing_start_date": "20220131"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-41)", "package_ndc": "0527-2415-41", "marketing_start_date": "20220131"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-43)", "package_ndc": "0527-2415-43", "marketing_start_date": "20220131"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-46)", "package_ndc": "0527-2415-46", "marketing_start_date": "20220131"}], "brand_name": "Bupropion hydrochloride (XL)", "product_id": "0527-2415_5e3c0247-0f79-454e-b14d-1e7dfd1a765e", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0527-2415", "generic_name": "Bupropion hydrochloride", "labeler_name": "Lannett Company Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride (XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA208652", "marketing_category": "ANDA", "marketing_start_date": "20180108", "listing_expiration_date": "20271231"}